BioNTech, Pfizer sue CureVac in U.S. over COVID-19 vaccine patent claims https://ift.tt/1xvzorj

BioNTech and Pfizer asked the Boston court to declare that their Comirnaty vaccine does not violate three CureVac patents related to RNA-based vaccines. The companies told the court that Comirnaty does not work in the same way as CureVac's patented technology.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/zwEDrVZ